Save on Pneumovax 23 with Coupons, Discounts & Savings Programs

Pneumovax 23 is the brand name for the polyvalent pneumococcal vaccine and is available as an intramuscular or subcutaneous injection.

Pneumovax 23 is available in a (0.5-mL dose) single-dose vial and a single-dose, prefilled syringe.

Pneumovax 23 is a vaccine and is used to prevent pneumococcal disease (infections caused by pneumococcus).

Pneumovax 23 is a vaccine that protects you against pneumococcal disease, an infection caused by the bacteria Streptococcus pneumoniae (also known as “pneumococcus”). This bacteria can infect many parts of the body and cause serious problems. Pneumovax 23 is also an inactivated vaccine that helps your body’s immune system make antibodies that will attack the bacteria if it ever infects you.

Pneumovax 23 is given as 1 injection into the muscle or under the skin of your shoulder or the outside of your mid-thigh. Depending on your age and medical conditions, you might need a second dose of Pneumovax 23, which is typically given at least 5 years after the first dose.

Pneumovax 23 is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. You should not use this medication if you have had a severe allergic reaction (e.g., anaphylaxis) to any component of
Pneumovax 23.

Common side effects of Pneumovax 23:

• Pain, soreness, or tenderness at the injection site
• Swelling at injection site
• Headache
• Redness at injection site
• Fatigue
• Muscle pain

Serious side effects are rare with Pneumovax 23. Contact your healthcare provider immediately if you experience any of the following.

• Serious allergic reactions: hives, dizziness, fever, rash, shaking, itching, nausea, flushing, shortness of breath, chest pain

The following medications may interact with Pneumovax 23:

• In a randomized clinical study, a reduced immune response to ZOSTAVAX® as measured by gpELISA was observed in individuals who received concurrent administration of Pneumovax 23 and ZOSTAVAX compared with individuals who received these vaccines 4 weeks apart. Consider administration of the two vaccines separated by at least 4 weeks

Merck & Co., Inc.

It is not known if Pneumovax 23 can harm your unborn baby. Pneumovax 23 should only be used during pregnancy if the benefit to you is worth the possible risk to your baby.

• Pneumococcal Vaccine Polyvalent